- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03782909
Evaluation of a Behavioural Intervention Using App Technology in CF (EAT-CF)
Evaluation of a Behavioural Intervention Using App Technology in Cystic Fibrosis
Cystic Fibrosis (CF) is a lifelong condition which causes the lungs and digestive system to become clogged with thick, sticky mucus. This leads to recurrent chest infections and reduced nutrient absorption from food. The average age at death is 31 years, usually from respiratory failure. The nutritional status of people with CF (PWCF) is important to help them live healthier and longer.
It is recommended that adults with CF achieve a BMI of 23 for males and 22 for females. However, fewer than 50% of adults with CF achieved that target BMI despite effective nutritional support to help weight gain. There is a clear need for a behavioural intervention that can help PWCF use the available nutritional support.
This is a feasibility study to try out a multi-component behavioural intervention supported by a nutrition app. The intervention is designed to help PWCF use their nutritional support to gain weight. It will focus on testing the methods and procedures to be used on a larger scale, improving the behavioural intervention and estimating how many people are needed for the larger trial.
Eligible patients will be invited to participate, and the investigators anticipate recruiting 6 participants. The participants will have 6 weeks of intensive intervention, which will include a mix of clinic visits, home visits and telephone calls followed by 6 weeks of maintenance phase. Data will be collected during clinic visits at baseline, week 6 and week 12 along with weight monitoring at home.
The investigators will interview each participant at the end of the study period to improve the intervention and study processes based on participant feedback.
The investigators hypothesised that using a nutrition app, along with regular input from a dietitian, will help PWCF to use the available nutritional support.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S10 2JF
- Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- adult people with CF looked after at the Sheffield Adult CF Centre
- best BMI of <23 for males and <22 for females between June 2018 and November 2018
Exclusion Criteria:
- patients in palliative phase of disease
- patients who are pregnant
- patients who have no capacity to consent to participate in the study
- patients who are unable to communicate by telephone for coaching
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behaviour change intervention
Intensive behaviour change for 6 weeks, followed by a maintenance phase for 6 weeks
|
The behaviour change intervention consists of;
The intensive phase consists of 2 home visits and 4 phone calls and the use of the app The maintenance phase consists of use of the app if the PWCF wishes to continue using it |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Proportion of patients who accepted invitation to participate as a marker of feasibility
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participants' opinion about the behavioural intervention
Time Frame: 3 months
|
A semi-structured interview will be used for thematic analysis
|
3 months
|
|
Participant attrition rate and phases of the study whereby the attrition occurs
Time Frame: 3 months
|
3 months
|
|
|
Participants' opinion about the study processes
Time Frame: 3 months
|
A semi-structured interview will be used for thematic analysis
|
3 months
|
|
Participants' suggestions for further improvement of the intervention and study processes
Time Frame: 3 months
|
A semi-structured interview will be used for thematic analysis
|
3 months
|
|
Proportion of adults who fulfils the BMI criteria for recruitment with IT facilities
Time Frame: 4 weeks
|
4 weeks
|
|
|
Resources (time) needed by the investigators to deliver the intervention
Time Frame: 3 months
|
Time will be used as a measurement tool to quantify total time required to deliver the intervention
|
3 months
|
|
Proportion of days with missing nutritional data, as a marker of feasibility
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH20240
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis (CF) | Cystic Fibrosis Gastrointestinal DiseaseUnited States
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingNon-cystic Fibrosis BronchiectasisChina
-
AstraZenecaRecruitingNon-cystic Fibrosis BronchiectasisChina
-
Reistone Biopharma Company LimitedRecruiting
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
Clinical Trials on Behaviour change intervention
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedCystic FibrosisUnited Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Wageningen UniversityRijnstate Hospital; Flevoziekenhuis; Deventer Ziekenhuis; World Cancer Research... and other collaboratorsCompletedColorectal Cancer | Rectal Cancer | Colon Cancer | Cancer-related FatigueNetherlands
-
Allurion TechnologiesCompleted
-
Chinese University of Hong KongActive, not recruitingChronic Kidney Diseases | Metabolic SyndromeChina
-
University of JyvaskylaRecruitingInactivity, Physical | Inactivity/Low Levels of ExerciseFinland
-
National University of MalaysiaUniversiti Putra Malaysia; University of RoehamptonCompletedAdolescent Obesity | Adolescent Behavior | Adolescent OverweightMalaysia
-
Concordia University, MontrealCentre de Recherche de l'Institut Universitaire de Geriatrie de MontrealActive, not recruiting
-
Jimma UniversityRecruitingKnowledge, Attitudes, Practice | Morbidity;Newborn | Breastfeeding, Exclusive | Complementary Feeding | Food Security | Integrated Community-based Intervention Package | Birth Preparedness and Complication Readiness Plan | Neonatal Care | Health Care Seeking Behavior | Delivery Care | Postnatal CareEthiopia
-
Boehringer IngelheimWithdrawnPulmonary Disease, Chronic Obstructive